HLS News: C2N Diagnostics and Healius Ltd Announce Partnership to Bring PrecivityAD™ and Related Brain He - 30th Aug 2022, 11:00pm

[annb0t]

ST. LOUIS, August 30, 2022--(BUSINESS WIRE)--C2N Diagnostics, a leader in advanced brain health diagnostics, and Healius Ltd (ASX:HLS), one of Australia's leading listed healthcare companies, today announced a partnership that will aim to bring C2N’s PrecivityAD™ blood test and related brain health biomarkers to the forefront of memory and dementia care in Australia. The partnership represents C2N’s first international country-wide agreement as it expands its offerings beyond the ...

>>> Read more: C2N Diagnostics and Healius Ltd Announce Partnership to Bring PrecivityAD™ and Related Brain Health Biomarkers to Patients in Australia